source
- Sanofi and Regeneron deepen collaboration, adding new immunology antibody programSanofi and Regeneron announced an expanded partnership that builds on the success of their joint drug Dupixet, targeting a pipeline of experimental antibodies for immunological disorders. Under th…
- Foghorn Therapeutics cuts 40% of workforce after ending Lilly oncology partnershipFoghorn Therapeutics and Eli Lilly announced the end of their 2021 oncology collaboration. The partnership had focused on developing and commercializing cancer treatments. Following the terminatio…